Influence of vessel diameter on the efficacy of distal protection devices during saphenous vein graft intervention

de Feyter, 1993, Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts, J Am Coll Cardiol, 21, 1539, 10.1016/0735-1097(93)90366-9 Holmes, 1995, A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions, Circulation, 91, 1966, 10.1161/01.CIR.91.7.1966 Hong, 1999, Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality, Circulation, 100, 2400, 10.1161/01.CIR.100.24.2400 Califf, 1998, Myonecrosis after revascularization procedures, J Am Coll Cardiol, 31, 241, 10.1016/S0735-1097(97)00506-8 Piana, 1994, Incidence and treatment of “no-reflow” after percutaneous coronary intervention, Circulation, 89, 2514, 10.1161/01.CIR.89.6.2514 Topol, 2000, Recognition of the importance of embolization in atherosclerotic vascular disease, Circulation, 101, 570, 10.1161/01.CIR.101.5.570 Baim, 2002, Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts, Circulation, 105, 1285, 10.1161/01.CIR.0000012783.63093.0C Stone, 2003, Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts, Circulation, 108, 548, 10.1161/01.CIR.0000080894.51311.0A Stone, 2002, Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy, J Am Coll Cardiol, 40, 1882, 10.1016/S0735-1097(02)02129-0 Grube, 2002, Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts, Am J Cardiol, 89, 941, 10.1016/S0002-9149(02)02243-9 Keeley, 2001, Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts, J Am Coll Cardiol, 38, 659, 10.1016/S0735-1097(01)01420-6 Ross, 2003, Angiographic variables predict increased risk for adverse ischemic events following coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial, J Am Coll Cardiol, 42, 981, 10.1016/S0735-1097(03)00913-6 Bruining, 1999, Quantitative measurements of in-stent restenosis: a comparison between quantitative coronary ultrasound and quantitative coronary angiography, Catheter Cardiovasc Intervention, 48, 133, 10.1002/(SICI)1522-726X(199910)48:2<133::AID-CCD3>3.0.CO;2-H Hoffmann, 1997, Overestimation of acute lumen gain and late lumen loss by quantitative coronary angiography (compared with intravascular ultrasound) in stented lesions, Am J Cardiol, 80, 1277, 10.1016/S0002-9149(97)00665-6 Michaels, 2002, Pretreatment with intragraft verapamil prior to percutaneous coronary intervention of saphenous vein graft lesions: results of the randomized, controlled vasodilator prevention on no-reflow (VAPOR) trial, J Invasive Cardiol, 14, 299